Company Profile
Twist Bioscience Corporation Stock Price, News & Analysis
Company overview
Business overview
Twist Bioscience is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Twist Bioscience is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Twist Bioscience follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Twist Bioscience sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Why the stock is moving
TWST is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Twist Bioscience's catalysts are synthetic-DNA demand, sequencing-library usage, and whether biopharma spending keeps improving. The company improves if the tools market keeps showing healthier demand.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue
Source: Twist Bioscience Corporation
- 02
Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results
Source: Twist Bioscience Corporation
- 03
Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes
Source: Twist Bioscience Corporation
- 04
Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement
Source: Twist Bioscience Corporation
- 05
Twist Bioscience to Present at Upcoming Investor Conferences
Source: Twist Bioscience Corporation
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.